Adult Dosing
Treatment of Allergic Rhinitis
Treatment of nasal congestion associated with seasonal allergic rhinitis
Prophylaxis of Seasonal Allergic Rhinitis
- 2 sprays/nostril qd initiated 2-4 wks prior to anticipated start of pollen season
Treatment of Nasal Polyps
- Adults
18 yrs: 2 sprays/nostril daily/bid
Pediatric Dosing
- Note: Safety and effectiveness in children <2 yrs of age have not been established
Allergic rhinitis, treatment
- Children 2-11 yrs: 1 spray/nostril daily
- Children 12 yrs: 2 sprays/nostril daily
Treatment of nasal congestion associated with seasonal allergic rhinitis
- Children 2-11 yrs: 1 spray/nostril daily
- Children 12 yrs: 2 sprays/nostril daily
Allergic rhinitis, prophylaxis
- Children 12 yrs: 2 sprays/nostril daily initiated 2-4 wks prior to anticipated start of pollen season
[Outline]
See Supplemental Patient Information
- May result in the development of glaucoma and/or cataracts; close monitoring is recommended in patients with a change in vision or with a history of increased intraocular pressure, glaucoma, and/or cataracts
- May cause hypersensitivity reactions including instances of wheezing; discontinue spray if such reactions occur
- If exposed to measles or chickenpox, consider anti-infective prophylactic therapy
- Corticosteroids may cause reduction in growth velocity in pediatric patients. Monitor growth routinely in pediatric patients
- Monitor for hypercorticism and Adrenal Suppression (if occur discontinue gradually)
- In long term treatment, periodically perform nasal examinations due to the risk of nasal septal perforation and localized infections
- Hypoadrenalism may occur in infants born to women receiving corticosteroids during pregnancy. Such infants should be carefully monitored
- Discontinue if nasopharyngeal candida infection occurs and appropriate local or systemic therapy instituted, if required
- Immunosuppression may result in more susceptibility to infections
Cautions: Use cautiously in
- Tuberculosis
- Untreated local or systemic infection
- Ocular herpes simplex
- Measles or varicella exposure
- Glaucoma
- Cataracts
- Increased IOP
- Vision changes
- Recurrent epistaxis
- Adrenal insufficiency
- Adrenal suppression/hypercorticism
- Long term use
Supplemental Patient Information
- Avoid use in eyes
- Advise patients to maintain regular regimen
- Persons on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles; advise patients that if they are exposed, medical advice should be sought without delay
Pregnancy Category:C
Breastfeeding: Safety unknown; however other corticosteroids are excreted in human milk, caution should be used when administered to nursing women.
Pricing data from www.DrugStore.com in U.S.A.
- Nasonex 50 MCG/ACT SUSP [Inhaler] (SCHERING)
17 act = $130.99
51 act = $365.98
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
